TrialBMJ open2022

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD).

Taku Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.